News & Publications

News

BeVigilant™ OraFusion™ System Released in Italy

BeVigilant™ OraFusion™ System Released in Italy

Vigilant Biosciences® Leads the Charge Against Oral Cancer Lakeway, Texas (Oct. 4, 2023) – Vigilant Biosciences®, Inc. (“Vigilant”), an industry-leading developer of cutting-edge solutions that accelerate the detection of oral cancer, announces the release of its...

read more
The Consequences of a Missed Oral Cancer Diagnosis

The Consequences of a Missed Oral Cancer Diagnosis

A missed cancer diagnosis can be devastating. However, unlike other malignancies, oral cancer is more likely to progress unnoticed until life-threatening stages. This is mainly due to misdiagnosis of early-stage signs and symptoms. One case review found that, among 35...

read more
The Limitations of Standard Oral Cancer Screening Methods

The Limitations of Standard Oral Cancer Screening Methods

No matter the type of cancer, an early-stage diagnosis is paramount to ensuring patient survival. For many, the journey to a diagnosis begins with a screening. Cancer screening is not intended to make an official diagnosis; however, these assessments can achieve two...

read more
Challenges in the Early Detection of Oral Cancer

Challenges in the Early Detection of Oral Cancer

Despite rapid innovation in cancer diagnostics and treatment, the oral cancer survival rate has yet to improve. Even after 40 years, the average survival rate has not surpassed 50% — an alarming figure spotlighting the need for more impactful diagnostic and treatment...

read more
When to Start Screening for Oral Cancer

When to Start Screening for Oral Cancer

Historically, oral cancer was thought to be an age-related malignancy; however, the growing prevalence of associated risk factors expands the demographic to younger age groups. This alarming shift brings to light the critical importance of proactive detection...

read more